Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma [Phase 2]
Avelumab was studied in a Phase 2 trial for relapsed or refractory peripheral T-cell lymphoma, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating toripalimab plus chidamide for relapsed/refractory peripheral T-cell lymphoma is currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy [Phase 2]
Phase 2 clinical trial results for tipifarnib in relapsed or refractory peripheral T-cell lymphoma have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-17Clinical Trial Update: Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL) [Phase 2]
Phase 2 study evaluating mogamulizumab (KW-0761) in previously treated peripheral T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) [Phase 2]
Phase 2 study results of Brentuximab Vedotin in Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma have been completed. The res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma [Phase 2]
The document notes a Phase 2 clinical trial evaluating CMOEP for untreated Peripheral T-cell lymphoma, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Linperlisib in combination with CHOP for previously untreated Peripheral T-cell lymphoma is currently …
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Minimal Residual Disease in Peripheral T-cell Lymphoma
This clinical trials update reports on minimal residual disease in peripheral T-cell lymphoma; the study has completed and is sponsored by W…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
A real-world registry study (TRUST) investigating molecular subtypes of Peripheral T-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma [Phase 1, Phase 2]
A clinical trial update announcing a Phase 1/2 study of SHR2554 in combination with chemotherapy for treatment-naïve peripheral T-cell lymph…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of romidepsin and lenalidomide in previously untreated peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma [Phase 3]
A Phase 3 clinical trial is investigating tucidinostat plus azacitidine and CHOP versus CHOP alone in untreated peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) [Phase 2]
Phase 2 study of SP-02L in relapsed or refractory Peripheral T-cell Lymphoma has completed; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study [Phase 1, Phase 2]
A Phase 1/2 prospective, multi-center study evaluating linperlisib in combination with chidamide for relapsed/refractory peripheral T-cell l…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating retreatment with brentuximab vedotin in classic Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma h…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL) [Phase 2]
A Phase 2 prospective, single-arm, single-center clinical trial evaluating duvelisib in combination with chidamide for newly diagnosed perip…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL [Phase 2, Phase 3]
Open-label, single-center, non-randomized study evaluating selinexor as maintenance therapy in patients with peripheral T-cell lymphoma who …
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma [Phase 1]
Phase 1 trial evaluating temsirolimus with etoposide and cyclophosphamide in children with relapsed acute lymphoblastic leukemia and non-Hod…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL [Phase 3]
A Phase 3 randomized trial comparing Chi-BEAM with BEAM + autologous stem cell transplant for newly diagnosed peripheral T-cell lymphoma is …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial investigating a targeted drug combined with CHOP for newly diagnosed peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for ASN002 in relapsed/refractory lymphoma and advanced solid tumors; the study status is TERMINATED with re…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides [Phase 2]
Phase II study of AFM13 in relapsed/refractory CD30-positive T-cell lymphoma and transformed mycosis fungoides completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin in combination chemotherapy for CD30-positive peripheral T-cell lymphomas reports results poste…
-
CLINICAL_TRIALS withdrawal · 2023-02-21Clinical Trial Update: CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) [Phase 2, Phase 3]
Clinical trial CELTIC-1 evaluating cerdulatinib in relapsed/refractory peripheral T-cell lymphoma has been withdrawn from the study.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating anti-PD-1 combined with lenalidomide and azacitidine in relapsed/refractory peripheral T-cell lymphoma i…